Male Infertility Panel
Summary and Pricing
Test Method
Exome Sequencing with CNV DetectionTest Code | Test Copy Genes | Panel CPT Code | Gene CPT Codes Copy CPT Code | Base Price | |
---|---|---|---|---|---|
4511 | Genes x (139) | 81479 | 81173(x1), 81222(x1), 81223(x1), 81400(x1), 81403(x1), 81404(x4), 81405(x3), 81406(x6), 81407(x1), 81479(x259) | $1290 | Order Options and Pricing |
Pricing Comments
We are happy to accommodate requests for testing single genes in this panel or a subset of these genes. The price will remain the list price. If desired, free reflex testing to remaining genes on panel is available. Alternatively, a single gene or subset of genes can also be ordered via our PGxome Custom Panel tool.
An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.
Click here for costs to reflex to whole PGxome (if original test is on PGxome Sequencing platform).
Click here for costs to reflex to whole PGnome (if original test is on PGnome Sequencing platform).
Turnaround Time
3 weeks on average for standard orders or 2 weeks on average for STAT orders.
Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.
Targeted Testing
For ordering sequencing of targeted known variants, go to our Targeted Variants page.
Clinical Features and Genetics
Clinical Features
Infertility is a disorder of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse. It affects 10-20% of couples worldwide, with male factor infertility accounting for about half of the cases.
In humans, sexual development and reproductive function occur by the actions of the hypothalamin-pituitary-gonadal axis induced by gonadotropin releasing hormone (GnRH). Aberrations in this axis can lead to pubertal and reproductive deficiencies. Diagnoses of infertility include hypogonadotropic hypogonadism, hypergonadotropic hypogonadism, and obstructive disorders (Layman. 2002. PubMed ID: 11897813). Male patients with hypogonadotropic hypogonadism often present a prepubertal testicular volume of less than 4 ml, absence of secondary sexual features (facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido and erectile dysfunction due to low serum gonadotropin, follicle stimulating hormone (FSH), and luteinizing hormone (LH; Balasubramanian et al. 2017. PubMed ID: 20301509). Hypergonadotropic hypogonadism in male patients is usually caused by testicular dysfunction (oligospermia, azoospermia, or other abnormalities of sperm morphology or motility).
Genetics
Infertility is a multifactorial complex condition with highly heterogeneous phenotypic representation. Genetic abnormalities, including both chromosomal and single gene alterations, can account for 15-30% of male factor infertility (Hotaling. 2014. PubMed ID: 24286764). Genetic causes can be detected in all major etiologic categories of male infertility (pre-testicular, testicular, and post-testicular forms). Genes and genomic regulation involved in male sexual development (SRY), testicular development (GATA4, NR5A1, NR0B1, WT1, DAX1, SOX9, ARX, ATRX), male genital tract development (AMH, AMHR1, AR, BMP4), and spermatogenesis (AURKC, SPATA16, DAZ, CFTR) have all been associated with male infertility (Miyamoto. 2015. PubMed ID: 26178295). Autosomal dominant, autosomal recessive, and X linked inheritance have been observed in male infertility genes.
Y chromosome microdeletion is the most common genetic cause of male infertility. For this reason, genetic testing to detect Y chromosome microdeleletions is strongly recommended in the case of a male patient with infertility. Please see our Y chromosome deletion analysis (test code 3740) if testing is desired. Sex chromosome aneuploidy, structural abnormality, and copy number variants (CNVs) are also common genetic causes of male infertility, and our CNV analysis enables these large cytogenetic abnormalities as well as some exon-level CNVs to be identified from NGS data.
See individual gene summaries for more information about molecular biology of gene products and spectra of pathogenic variants.
Clinical Sensitivity - Sequencing with CNV PGxome
This multi-gene panel analyzes genes involved in both syndromic and non-syndromic male infertility (Baxter. 2015. PubMed ID: 25383892). The detection rate of this NGS panel in a large cohort of infertile male patients is unavailable in the literature. However, in patients with hypogonadotropic hypogonadism, 40-50% of patients have pathogenic variants in 28 genes in this panel.
At this time, the clinical sensitivity of Copy Number Variant (CNV) testing is difficult to estimate due to the lack of large cohort studies. So far, CNVs have been reported in SOX3, LHCGR, SRY, NR0B1, DMRT1, NR5A1, GATA4, WT1, WNT4, and FGFR2.
Testing Strategy
This test is performed using Next-Gen sequencing with additional Sanger sequencing as necessary.
This panel typically provides 99.1% coverage of all coding exons of the genes plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define coverage as ≥20X NGS reads or Sanger sequencing.
Dependent on the sequencing backbone selected for this testing, discounted reflex testing to any other similar backbone-based test is available (i.e., PGxome panel to whole PGxome; PGnome panel to whole PGnome).
Indications for Test
This test is recommended for men with genetic infertility.
This test is recommended for men with genetic infertility.
Genes
Inheritance | Abbreviation |
---|---|
Autosomal Dominant | AD |
Autosomal Recessive | AR |
X-Linked | XL |
Mitochondrial | MT |
Diseases
Related Test
Name |
---|
PGxome® |
Citations
Ordering/Specimens
Ordering Options
We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.
myPrevent - Online Ordering
- The test can be added to your online orders in the Summary and Pricing section.
- Once the test has been added log in to myPrevent to fill out an online requisition form.
- PGnome sequencing panels can be ordered via the myPrevent portal only at this time.
Requisition Form
- A completed requisition form must accompany all specimens.
- Billing information along with specimen and shipping instructions are within the requisition form.
- All testing must be ordered by a qualified healthcare provider.
For Requisition Forms, visit our Forms page
If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.
Specimen Types
Specimen Requirements and Shipping Details
PGxome (Exome) Sequencing Panel
PGnome (Genome) Sequencing Panel
ORDER OPTIONS
View Ordering Instructions1) Select Test Type
2) Select Additional Test Options
No Additional Test Options are available for this test.